Literature DB >> 26802140

Long-term Protection After Hepatitis B Vaccine.

Pierre Van Damme1.   

Abstract

Keywords:  duration; hepatitis B; protection; vaccine

Mesh：

Substances：

Year:  2016        PMID： 26802140     DOI： 10.1093/infdis/jiv750

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  The effects of aflatoxin exposure on Hepatitis B-vaccine induced immunity in Kenyan children.

Authors:  D Githang'a; R N Wangia; M W Mureithi; S O Wandiga; C Mutegi; B Ogutu; A Agweyu; J-S Wang; O Anzala
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2019-05-16

2.  Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.

Authors:  Luisa Romanò; Cristina Galli; Catia Tagliacarne; Maria Elena Tosti; Claudio Velati; Laura Fomiatti; Maria Chironna; Rosa Cristina Coppola; Mario Cuccia; Rossana Mangione; Fosca Marrone; Francesco Saverio Negrone; Antonino Parlato; Carla Maria Zotti; Alfonso Mele; Alessandro Remo Zanetti
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

3.  Evaluation of response to hepatitis B vaccine in Iranian 6-18-year-old students.

Authors:  Alizamen Salehifard Jouneghani; Morteza Hashemzadeh Chaleshtori; Abolfazl Khoshdel; Soleiman Kheiri; Effat Farrokhi; Pooran Khalafian; Zahra Aliyari
Journal:  J Res Med Sci       Date:  2017-10-31       Impact factor: 1.852

Review 4.  Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?

Authors:  Hong Zhao; Yi-Hua Zhou
Journal:  Hum Vaccin Immunother       Date:  2017-12-06       Impact factor: 3.452

5.  Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014.

Authors:  Alessandro Miglietta; Chantal Quinten; Pier Luigi Lopalco; Erika Duffell
Journal:  Euro Surveill       Date:  2018-02

6.  Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines.

Authors:  Timo Vesikari; Jin Xu; David R Johnson; Jessie Hall; Tomáš Marček; Michelle G Goveia; Camilo J Acosta; Andrew Wen-Tseng Lee
Journal:  Hum Vaccin Immunother       Date:  2019-11-05       Impact factor: 3.452

7.  Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults.

Authors:  Pierre Van Damme; Marc Dionne; Geert Leroux-Roels; Olivier Van Der Meeren; Emmanuel Di Paolo; Bruno Salaun; Pemmaraju Surya Kiran; Nicolas Folschweiller
Journal:  J Viral Hepat       Date:  2019-06-02       Impact factor: 3.728

8.  Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.

Authors:  Pierre Van Damme; Geert Leroux-Roels; P Suryakiran; Nicolas Folschweiller; Olivier Van Der Meeren
Journal:  Hum Vaccin Immunother       Date:  2017-03-10       Impact factor: 3.452

9.  Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

Authors:  Evan J Anderson; Nadine G Rouphael; Alicia T Widge; Lisa A Jackson; Paul C Roberts; Mamodikoe Makhene; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian B McDermott; Britta Flach; Bob C Lin; Nicole A Doria-Rose; Sijy O'Dell; Stephen D Schmidt; Kizzmekia S Corbett; Phillip A Swanson; Marcelino Padilla; Kathy M Neuzil; Hamilton Bennett; Brett Leav; Mat Makowski; Jim Albert; Kaitlyn Cross; Venkata Viswanadh Edara; Katharine Floyd; Mehul S Suthar; David R Martinez; Ralph Baric; Wendy Buchanan; Catherine J Luke; Varun K Phadke; Christina A Rostad; Julie E Ledgerwood; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-09-29       Impact factor: 91.245

10.  Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.

Authors:  Ning Miao; Hui Zheng; Xiaojin Sun; Guomin Zhang; Fuzhen Wang
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.